Diego Brandao fails USADA drug test for marijuana


Josh Hedges|Zuffa LLC|Zuffa LLC

UFC featherweight Diego Brandao was informed by the U.S. Anti-Doping Agency (USADA) earlier this week that he potentially violated the anti-doping policy in a post-fight drug test following UFC 195 earlier this month. According to UFC officials, Brandao failed a drug test for Carboxy-Tetrahydrocannabinol, a metabolite of marijuana and/or hashish, as he was above the limit of 180 ng/mL. Check out part of the UFC's statement below:
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Brandao, as it relates to the UFC Anti-Doping Policy and future UFC participation. Because the Nevada State Athletic Commission was the regulatory body overseeing the fight in Las Vegas and has state licensing and jurisdiction over Brandao, USADA will work to ensure that the Commission has the necessary information to determine its proper judgment of Brandao’s potential anti-doping violation. Additional information will be provided at the appropriate time as the process moves forward.
No details regarding a suspension for Brandao have been made public at this time. Brandao fought rising star Brian Ortega on the pay-per-view main card of UFC 195. After a solid first two rounds for the Brazilian veteran, he was submitted by Ortega in the third round. Prior to the loss, he was riding a two-fight winning streak with stoppages over Katsunori Kikuno and Jimy Hettes. Keep it locked to MMAjr.co for the latest news on this situation.

Leave a Reply

Your email address will not be published. Required fields are marked *